A comprehensive view of Eye Drops. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Bausch + Lomb receive Health Canada approval for Lumify brimonidine tartrate ophthalmic solution 0.025% w/v OTC eye drop to relieve eye redness; product available in 3.5 mL and 7.5 mL sizes, is first OTC eye drop of its kind in Canada
Published: May 31, 2022 by Canada Newswire
Eye therapy firm Kala Pharmaceuticals sells its commercial portfolio, related intellectual assets to Alcon Inc. for US$60M; deal includes FDA-approved Eysuvis treatment for dry eye disease, Inveltys corticosteroid for treatment after ocular surgery
Published: May 24, 2022 by GlobeNewswire
Pharmapack Awards winners announced; Korber Pharma Packaging Materials wins for recyclable Pharmaceutical Grass Paper Packaging, and Activated Rispharm antimicrobial eye dropper by Berry Global and Pylote wins Packaging Innovation category
Published: May 19, 2022 by PharmaBiz
Berry Global, PYLOTE to introduce Activated Rispharm multidose antimicrobial dropper for eye products at upcoming Pharmapack 2022 in Paris; Pylote's patented mineral technology--microspheres--is embedded into the resin masterbatch and is fully recyclable
Published: May 11, 2022 by Berry Global Group Inc.
Sandoz introduces generic version of AbbVie’s Combigan combination eye drop to treat glaucoma in US in three dosing strengths; Combigan is most-used eye pressure medication, with US sales totaling US$373M in 2021
Published: April 28, 2022 by Indian Pharma Industry : Policies

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count